Terms: = Germ cell tumor AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Prognosis
20 results:
1. Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis.
Vuong HG; Alzayadneh E; Reith TP; Eschbacher KL
Pathol Res Pract; 2023 Dec; 252():154922. PubMed ID: 37984047
[TBL] [Abstract] [Full Text] [Related]
2. Oncogenic Fusions in Gliomas: An Institutional Experience.
Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
[TBL] [Abstract] [Full Text] [Related]
3. fgfr2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.
Ando K; Ohira M; Takada I; Cázares-Ordoñez V; Suenaga Y; Nagase H; Kobayashi S; Koshinaga T; Kamijo T; Makishima M; Wada S
Cancer Sci; 2022 Feb; 113(2):587-596. PubMed ID: 34807483
[TBL] [Abstract] [Full Text] [Related]
4. Molecular characterization of fast-growing melanomas.
Gaudy-Marqueste C; Macagno N; Loundou A; Pellegrino E; Ouafik L; Budden T; Mundra P; Gremel G; Akhras V; Lin L; Cook M; Kumar R; Grob JJ; Nagore E; Marais R; Virós A
J Am Acad Dermatol; 2022 Feb; 86(2):312-321. PubMed ID: 34280484
[TBL] [Abstract] [Full Text] [Related]
5. Novel targetable fgfr2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs.
Georgescu MM; Islam MZ; Li Y; Traylor J; Nanda A
Acta Neuropathol Commun; 2021 Apr; 9(1):69. PubMed ID: 33853673
[TBL] [Abstract] [Full Text] [Related]
6. Pembrolizumab in Patients with Advanced Metastatic germ cell tumors.
Tsimberidou AM; Vo HH; Subbiah V; Janku F; Piha-Paul S; Yilmaz B; Gong J; Naqvi MF; Tu SM; Campbell M; Meric-Bernstam F; Naing A
Oncologist; 2021 Jul; 26(7):558-e1098. PubMed ID: 33491277
[TBL] [Abstract] [Full Text] [Related]
7. Surgical treatment and prognosis of focal brainstem gliomas in children: A 7 year single center experience.
Sun T; Xu Y; Pan C; Liu Y; Tian Y; Li C; Di F; Zhang L
Medicine (Baltimore); 2020 Sep; 99(36):e22029. PubMed ID: 32899058
[TBL] [Abstract] [Full Text] [Related]
8. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract] [Full Text] [Related]
9. Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal cell Carcinoma Treated With Sunitinib.
Vanmechelen M; Lambrechts D; Van Brussel T; Verbiest A; Couchy G; Schöffski P; Dumez H; Debruyne PR; Lerut E; Machiels JP; Richard V; Albersen M; Verschaeve V; Oudard S; Méjean A; Wolter P; Zucman-Rossi J; Beuselinck B
Clin Genitourin Cancer; 2019 Apr; 17(2):e235-e246. PubMed ID: 30527746
[TBL] [Abstract] [Full Text] [Related]
10. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Kuo SH; Yang SY; You SL; Lien HC; Lin CH; Lin PH; Huang CS
Oncotarget; 2017 Mar; 8(13):20925-20938. PubMed ID: 28178648
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
[TBL] [Abstract] [Full Text] [Related]
12. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
[TBL] [Abstract] [Full Text] [Related]
13. Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma.
Ohashi R; Matsuda Y; Ishiwata T; Naito Z
Oncol Rep; 2014 Sep; 32(3):1163-9. PubMed ID: 24968791
[TBL] [Abstract] [Full Text] [Related]
14. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
Chiang JH; Cheng WS; Hood L; Tian Q
OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
[TBL] [Abstract] [Full Text] [Related]
15. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
[TBL] [Abstract] [Full Text] [Related]
16. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.
Salm F; Cwiek P; Ghosal A; Lucia Buccarello A; Largey F; Wotzkow C; Höland K; Styp-Rekowska B; Djonov V; Zlobec I; Bodmer N; Gross N; Westermann F; Schäfer SC; Arcaro A
Oncogene; 2013 Aug; 32(34):3944-53. PubMed ID: 23027129
[TBL] [Abstract] [Full Text] [Related]
17. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.
Stacey SN; Manolescu A; Sulem P; Thorlacius S; Gudjonsson SA; Jonsson GF; Jakobsdottir M; Bergthorsson JT; Gudmundsson J; Aben KK; Strobbe LJ; Swinkels DW; van Engelenburg KC; Henderson BE; Kolonel LN; Le Marchand L; Millastre E; Andres R; Saez B; Lambea J; Godino J; Polo E; Tres A; Picelli S; Rantala J; Margolin S; Jonsson T; Sigurdsson H; Jonsdottir T; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Sveinsdottir SG; Alexiusdottir K; Saemundsdottir J; Sigurdsson A; Kostic J; Gudmundsson L; Kristjansson K; Masson G; Fackenthal JD; Adebamowo C; Ogundiran T; Olopade OI; Haiman CA; Lindblom A; Mayordomo JI; Kiemeney LA; Gulcher JR; Rafnar T; Thorsteinsdottir U; Johannsson OT; Kong A; Stefansson K
Nat Genet; 2008 Jun; 40(6):703-6. PubMed ID: 18438407
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.
Tada K; Shiraishi S; Kamiryo T; Nakamura H; Hirano H; Kuratsu J; Kochi M; Saya H; Ushio Y
J Neurosurg; 2001 Oct; 95(4):651-9. PubMed ID: 11596960
[TBL] [Abstract] [Full Text] [Related]
19. The use of molecular biology in diagnosis and prognosis of gastric cancer.
Becker KF; Keller G; Hoefler H
Surg Oncol; 2000 Jul; 9(1):5-11. PubMed ID: 11525306
[TBL] [Abstract] [Full Text] [Related]
20. Gastric adenocarcinoma: pathomorphology and molecular pathology.
Werner M; Becker KF; Keller G; Höfler H
J Cancer Res Clin Oncol; 2001 Apr; 127(4):207-16. PubMed ID: 11315254
[TBL] [Abstract] [Full Text] [Related]